• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: Lenvatinib inhibits the growth of gastric cancer patient‑derived xenografts generated from a heterogeneous populations.

作者信息

Karalis John D, Yoon Lynn Y, Hammer Suntrea T G, Hong Changjin, Zhu Min, Nassour Ibrahim, Ju Michelle R, Xiao Shu, Castro-Dubon Esther C, Agrawal Deepak, Suarez Jorge, Reznik Scott I, Mansour John C, Polanco Patricio M, Yopp Adam C, Zeh Iii Herbert J, Hwang Tae Hyun, Zhu Hao, Porembka Matthew R, Wang Sam C

机构信息

Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Children's Research Institute, Departments of Pediatrics and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

J Transl Med. 2024 Sep 13;22(1):842. doi: 10.1186/s12967-024-05632-7.

DOI:10.1186/s12967-024-05632-7
PMID:39272170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11396437/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b3/11396437/3adc95b129a8/12967_2024_5632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b3/11396437/020677817e89/12967_2024_5632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b3/11396437/3adc95b129a8/12967_2024_5632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b3/11396437/020677817e89/12967_2024_5632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b3/11396437/3adc95b129a8/12967_2024_5632_Fig2_HTML.jpg

相似文献

1
Correction to: Lenvatinib inhibits the growth of gastric cancer patient‑derived xenografts generated from a heterogeneous populations.更正：乐伐替尼抑制源自异质群体的胃癌患者来源异种移植瘤的生长。
J Transl Med. 2024 Sep 13;22(1):842. doi: 10.1186/s12967-024-05632-7.
2
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.仑伐替尼抑制源自异质人群的胃癌患者来源异种移植物的生长。
J Transl Med. 2022 Mar 7;20(1):116. doi: 10.1186/s12967-022-03317-7.
3
Patient‑derived orthotopic xenograft glioma models fail to replicate the magnetic resonance imaging features of the original patient tumor.患者来源的原位异种移植脑胶质瘤模型无法复制原始患者肿瘤的磁共振成像特征。
Oncol Rep. 2020 May;43(5):1619-1629. doi: 10.3892/or.2020.7538. Epub 2020 Mar 9.
4
Xenograft and organoid models in developing precision medicine for gastric cancer (Review).异种移植和类器官模型在胃癌精准医学发展中的应用（综述）。
Int J Oncol. 2024 Apr;64(4). doi: 10.3892/ijo.2024.5629. Epub 2024 Feb 23.
5
Lenvatinib acts on platelet‑derived growth factor receptor β to suppress the malignant behaviors of gastric cancer cells.乐伐替尼作用于血小板衍生生长因子受体β，以抑制胃癌细胞的恶性行为。
Oncol Lett. 2024 Aug 7;28(4):483. doi: 10.3892/ol.2024.14616. eCollection 2024 Oct.
6
Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models.乐伐替尼（E7080）的抗肿瘤活性：一种在临床前人类甲状腺癌模型中靶向多种受体酪氨酸激酶的血管生成抑制剂。
J Thyroid Res. 2014;2014:638747. doi: 10.1155/2014/638747. Epub 2014 Sep 10.
7
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models.仑伐替尼抑制人肝癌模型中的血管生成和肿瘤成纤维细胞生长因子信号通路。
Cancer Med. 2018 Jun;7(6):2641-2653. doi: 10.1002/cam4.1517. Epub 2018 May 7.
8
Cabozantinib inhibits the growth of lenvatinib-resistant hepatoma cells restoring FTCD expression.卡博替尼抑制仑伐替尼耐药肝癌细胞的生长，恢复 FTCD 表达。
Biochem Pharmacol. 2024 Aug;226:116321. doi: 10.1016/j.bcp.2024.116321. Epub 2024 May 28.
9
Efficient primary culture model of patient‑derived tumor cells from colorectal cancer using a Rho‑associated protein kinase inhibitor and feeder cells.利用 Rho 相关蛋白激酶抑制剂和饲养细胞建立高效的结直肠癌患者来源肿瘤细胞原代培养模型。
Oncol Rep. 2019 Nov;42(5):2029-2038. doi: 10.3892/or.2019.7285. Epub 2019 Aug 20.
10
Lenvatinib inhibits intrahepatic cholangiocarcinoma via Gadd45a-mediated cell cycle arrest.乐伐替尼通过Gadd45a介导的细胞周期阻滞抑制肝内胆管癌。
Discov Oncol. 2023 Feb 23;14(1):26. doi: 10.1007/s12672-023-00631-4.

引用本文的文献

1
Enriched environment inhibits GLT-1 ubiquitination by downregulating SMURF1 to attenuate ischemic brain injury induced excitotoxicity.丰富环境通过下调SMURF1抑制GLT-1泛素化，以减轻缺血性脑损伤诱导的兴奋性毒性。
Cell Biosci. 2025 Aug 28;15(1):124. doi: 10.1186/s13578-025-01457-z.

本文引用的文献

1
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.仑伐替尼抑制源自异质人群的胃癌患者来源异种移植物的生长。
J Transl Med. 2022 Mar 7;20(1):116. doi: 10.1186/s12967-022-03317-7.